twist is a potential oncogene that inhibits apoptosis

Genes and Development

Volumn 13, Issue 17, 1999, Pages 2207-2217

  Maestro, Roberta ^a,b   Dei Tos, Angelo P ^c   Hamamori, Yasuo ^d   Krasnokutsky, Svetlana ^b   Sartorelli, Vittorio ^d   Kedes, Larry ^d   Doglioni, Claudio ^e   Beach, David H ^f   Hannon, Gregory J ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Simons Center for Quantitative Biology   (United States)

^c Treviso City Hospital   (Italy)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e Belluno City Hospital   (Italy)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Dermol; Oncogenes; Tumorigenesis; Twist

Indexed keywords

COMPLEMENTARY DNA; DNA; ONCOPROTEIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; GENE ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033200349     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.17.2207     Document Type: Article

References (62)

1. Agarwal, M.L., W.R. Taylor, M.V. Chernov, O.B. Chernova, and G.R. Stark. 1998. The p53 network. J. Biol. Chem. 273: 1-4.
2. Attardi, L.D., S.W. Lowe, J. Brugarolas, and T. Jacks. 1996. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15: 3693-3701.
3. Avantaggiati, M.L., V. Ogryzko, K. Gardner, A. Giordano, A.S. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89: 1175-1184.
4. Bates, S., A.C. Phillips, P.A. Clark, F. Stott, G. Peters, R.L. Ludwig, and K.H. Vousden. 1998 p14ARF links the tumor suppressors RB and p53. Nature 395: 124-125.
5. Bourez, R.L., I.M. Mathijssen, J.M. Vaandrager, and C. Vermeij-Keers. 1997. Apoptotic cell death during normal embryogenesis of the coronal suture: Early detection of apoptosis in mice using annexin V. J. Craniofac. Surg. 8: 441-445.
6. Chen, X., L.J. Ko, L. Jayaraman, and C. Prives. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes & Dev. 10: 2438-2451.
7. Chen, Z.F. and R.R. Behringer. 1995. twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes & Dev. 9: 686-699.
8. Debbas, M. and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev. 7: 546-554.
9. DeGregori, J., G. Leone, A. Miron, L. Jokoi, and J.R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. 94: 7245-7250.
10. Deiss, L.P. and A. Kimchi. 1991. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252: 117-120.
11. De Stanchina, E.; M.E. McCurrach, F. Zindy, S.-Y. Shieh, G. Ferbeyre, A.V. Samuelson, C. Prives, M.F. Roussel, C.J. Sherr, and S.W. Lowe. 1998. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes & Dev. 12: 2434-2442.
12. el Ghouzzi, V., M. Le Mener, F. Perrin-Schmitt, E. Lajeunie, P. Benit, D. Renier, P. Bourgeois, A.L. Bolcato-Bellemin, A. Munnich, and J. Bonaventure. 1997. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 15: 42-46.
13. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
14. Fuchtbauer, E.M. 1995. Expression of M-twist during postimplantation development of the mouse. Dev. Dyn. 204:316-322.
15. Gitelman, I. 1997. Twist protein in mouse embryogenesis. Dev. Biol. 189: 205-214.
16. Grossman, S.R., M. Perez, A.L. Kung, M. Joseph, C. Mansur, Z. Xiao, S. Kumar, P.M. Howley, and D.M. Livingston. 1998. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell 2: 405-415.
17. Gu, W., X.L. Shi, and R.G. Roeder. 1997. Synergistic activation of transcription by CBP and p53. Nature 387: 819-823.
18. Gudkov, A.V. and I.E. Roninson. 1997, Isolation of genetic suppressor elements (GSEs) from random fragment cDNA libraries in retroviral vectors. Methods Mol. Biol. 69: 221-240.
19. Gudkov, A.V, A.R. Kazarov, R. Thimmapaya, S.A. Axenovich, I.A. Mazo, and I.E. Roninson. 1994. Cloning mammalian genes by expression selecion of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization. Proc. Natl Acad. Sci. 91: 3744-3748.
20. Hamamori, Y., W. Hung-Yi, V. Sartorelli, and L. Kedes. 1997. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol. Cell. Biol. 17: 6563-6573.
21. Hamamori, Y., V. Sartorelli, V. Ogryzko, P.L. Puri, H.Y. Wu, J.Y. Wang, Y. Nakatani, and L. Kedes. 1999. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral E1A. Cell 96: 405-413.
22. Hannon, G.J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p 130 through its interaction with CDK2 and cyclins. Genes & Dev. 7: 2378-2391.
23. Hannon, G.J., P. Sun, A. Carnero, L.Y. Xie, R. Maestro, D. Conklin, and D. Beach. 1999. Genetics in mammalian cells. Science 283: 1129-1130.
24. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
25. Hebrok, M., A. Fuchtbauer, and E.M. Fuchtbauer. 1997. Repression of muscle-specific gene activation by the murine Twist protein. Exp. Cell Res. 232: 295-303.
26. Hermeking, H. and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093.
27. Hockenbery, D.M., Z.N. Oltvai, X.M. Yin, C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251.
28. Honda, R. and H. Yasuda. 1999 Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18: 22-27.
29. Howard, T.D., W.A. Paznekas, E.D. Green, L.C. Chiang, N. Ma, R.I. Ortiz de Luna, C. Garcia Delgado, M. Gonzalez-Ramos, A.D. Kline, and E.W. Jabs. 1997. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 15: 36-41.
30. Kamijo, T., J.D. Weber, G. Zambetti, F. Zindy, M.F. Roussel, and C.J. Sherr. 1998. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. 95: 822-829.
31. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signaling through PI(3)K and PKB. Nature 385: 544-548.
32. Kimchi, A. 1998. DAP genes: Novel apoptotic genes isolated by a functional approach to gene cloning. Biochim. Biophys. Acta 1377: F13-F33.
33. Ko, L.J. and C. Prives. 1996. p53: Puzzle and paradigm. Genes & Dev. 10: 1054-1072.
34. Kozopas, K.M., T. Yang, H.L. Buchan, P. Zhou, and R.W. Craig. 1993. MCL1 a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. 90: 3516-3520.
35. Kubbutat, M.H., S.N. Tones, and K.H. Voudsen. 1997. Regulation of p53 stability by Mdm2. Nature 278: 261-263.
36. Li, L., P. Cserjesi, and E.N. Olson. 1995. Dermo-1: A novel twist-related bHLH protein expressed in the developing dermis. Dev. Biol. 172: 280-292.
37. Lill, N.L., S.R. Grossman, D. Ginsberg, J. DeCaprio, and D.M. Livingston. 1997. Binding and modulation of p53 by p300/ CBP coactivators. Nature 387: 823-827.
38. Lin, A.W., M. Barradas, J.C. Stone, L. van Aelst, M. Serrano, and S.W. Lowe. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes & Dev. 12: 3008-3019.
39. Lowe, S.W. and H.E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes & Dev. 7: 535-545.
40. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 74: 957-967.
41. Lowe, S.W., T. Jacks, D.E. Housman, and H.E. Ruley. 1994. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. 91: 2026-2030.
42. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671-680.
43. Nikiforov, M.A., K. Hagen, V.S. Ossovskaya, T.M. Connor, S.W. Lowe, G.I. Deichman, and A.V. Gudkov. 1996. p53 modulation of anchorage independent growth and experimental metastasis. Oncogene 13: 1709-1719.
44. Pappo, A.S. 1996. Rhabdomyosarcoma and other soft tissue sarcomas in children. Curr. Opin. Oncol. 8: 311-316.
45. Quelle, D.E., F. Zindy, R.A. Ashmun, and C.J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000.
46. Rayner, J.R. and T.J. Gonda. 1994. A simple and efficient procedure for generating stable expression libraries by cDNA cloning in a retroviral vector. Mol. Cell. Biol. 14: 880-887.
47. Robertson, K.D. and P.A. Jones. 1998. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wildtype p53. Mol. Cell. Biol. 18: 6457-6473.
48. Serrano, M., A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
49. Shieh, S.Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334.
50. Siciliano, J.D., C.E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M.B. Kastan. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes & Dev. 11: 3471-3481.
51. Soengas, M.S., R.M. Alarcon, H. Yoshida, A.J. Giaccia, R. Hakem, T.W. Mak, and S.W. Lowe. 1999. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284: 156-159.
52. Spicer, D.B., J. Rhee, W.L. Cheung, and A.B. Lassar. 1996. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272: 1476-1480.
53. Sun, P., P. Dong, K. Dai, G.J. Hannon, and D. Beach. 1998. p53-independent role of MDM2 in TGF-β resistance. Science 282: 2270-2272.
54. Thisse, B., M. el Messal, and F. Perrin-Schmitt. 1987. The twist gene: Isolation of a Diosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res. 15: 3439-3453.
55. Vaux, D.L., S. Cory, and J.M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
56. Vogelstein, B. and K.W. Kinzler. 1998. The genetic basis of human cancer. McGraw-Hill, New York, NY.
57. Wagner, A.J., J.M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/ cipl. Genes & Dev. 23: 2817-2830.
58. Weber, J.D., L.J. Taylor, M.F. Roussel, C.J. Sherr, and D. BarSagi. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1: 20-26.
59. Wong, B.Y., H. Chen, S.W. Chung, and P.M. Wong. 1994. High-efficiency identification of genes by functional analysis from a retroviral cDNA library. J. Virol. 68: 5523-5531.
60. Zhang, Y. and Y. Xiong. 1999. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3: 579-591.
61. Zhang, Y., Y. Xiong, and W.G. Yarbrough. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734.
62. Zindy, F., C.M. Eischen, D.H. Randle, T. Kamijo, J.L. Cleveland, C.J. Sherr, and M.R. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes & Dev. 12: 2424-2433.